UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
The current UroGen Pharma(URGN) stock price is $18.82, with a market capitalization of 917.17M. The stock trades at a price-to-earnings (P/E) ratio of -5.86.
During the trading session on 2026-04-03, UroGen Pharma(URGN) shares reached a daily high of $19.20 and a low of $18.44. At a current price of $18.82, the stock is +2.1% higher than the low and still -2.0% under the high.
Trading volume for UroGen Pharma(URGN) stock has reached 381.35K, versus its average volume of 637.48K.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
URGN News
UroGen Pharma (URGN) announced the publication of results from the pivotal Phase 3 ENVISION trial of Zusduri for intravesical solution in The Journal of Urology...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.